Biochemistry and pharmacology of S-adenosyl-L-methionine and rationale for its use in liver disease.
Role of S-adenosyl-L-methionine in the treatment of alcoholic liver disease: introduction and summary of the symposium.
S-adenosyl-L-methionine antagonizes oral contraceptive-induced bile cholesterol supersaturation in healthy women: preliminary report of a controlled randomized trial.
Electrophysiological neuroimaging of the central effects of S-adenosyl-L-methionine by mapping of electroencephalograms and event-related potentials and low-resolution brain electromagnetic tomography.
Pharmacodynamic studies on the central mode of action of S-adenosyl-L-methionine (SAMe) infusions in elderly subjects, utilizing EEG mapping and psychometry.
Inhibition of mouse-killing behavior by S-adenosyl-L-methionine in midbrain raphe-lesioned and olfactory-bulbectomized rats.
Callers should ask for Report #64: Evidence Report on S-Adenosyl-L-Methionine for treatment in Depression, Osteoarthritis, and Liver Disease.
SAMe is an acronym for S-adenosyl-L-methionine, a natural compound found in every human cell and involved in over 35 biochemical processes in the body.
8) Baldessarini RJ: Neuropharmacology of S-adenosyl-L-methionine.
Cerbo R: Effect of S-adenosyl-L-methionine (SAMe) upon depressive symptoms.
S-Adenosyl-L-methionine and mitochondrial reduced glutathione depletion in alcoholic liver disease.
Anti-inflammatory and analgesic action of S-adenosyl-L-methionine (SAMe) in experimental tests on laboratory animals.